These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3260232)

  • 21. Determination of MIC and disk diffusion quality control guidelines for meropenem-vaborbactam, a novel carbapenem/boronic acid β-lactamase inhibitor combination.
    Munson E; Huband MD; Castanheira M; Fedler KA; Flamm RK
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):324-328. PubMed ID: 29276104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-681,217, a new and novel member of the efrotomycin family of antibiotics.
    Kempf AJ; Wilson KE; Hensens OD; Monaghan RL; Zimmerman SB; Dulaney EL
    J Antibiot (Tokyo); 1986 Oct; 39(10):1361-7. PubMed ID: 3781906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purpuromycin, a new antibiotic isolated from Actinoplanes ianthinogenes N. sp.
    Coronelli C; Pagani H; Bardone MR; Lancini GC
    J Antibiot (Tokyo); 1974 Mar; 27(3):161-8. PubMed ID: 4836652
    [No Abstract]   [Full Text] [Related]  

  • 24. FR-900318, a novel penicillin with beta-lactamase inhibitory activity.
    Yamashita M; Hashimoto S; Ezaki M; Iwami M; Komori T; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1774-6. PubMed ID: 6319348
    [No Abstract]   [Full Text] [Related]  

  • 25. Glycothiohexide alpha, a novel antibiotic produced by "Sebekia" sp., LL-14E605. II. Isolation and physical-chemical characterization.
    Northcote PT; Williams D; Manning JK; Borders DB; Maiese WM; Lee MD
    J Antibiot (Tokyo); 1994 Aug; 47(8):894-900. PubMed ID: 7928676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1 beta-Methyl-2(5-substituted pyrrolidin-3-ylthio)carbapenems. 1. Synthesis and antibacterial activity of BO-2502A and its related compounds.
    Ohtake N; Yamada K; Mano E; Okamoto O; Ushijima R; Nakagawa S
    J Antibiot (Tokyo); 1997 Jul; 50(7):567-85. PubMed ID: 9711249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-19393 S2 and H2, new carbapenem antibiotics. IV. Inhibitory activity against beta-lactamases.
    Okonogi K; Nozaki Y; Imada A; Kuno M
    J Antibiot (Tokyo); 1981 Feb; 34(2):212-7. PubMed ID: 6975270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally-occurring beta-lactamase inhibitors with antibacterial activity.
    Brown AG; Butterworth D; Cole M; Hanscomb G; Hood JD; Reading C; Rolinson GN
    J Antibiot (Tokyo); 1976 Jun; 29(6):668-9. PubMed ID: 950324
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluvirucin B6, a new macrolactam isolated from a marine-derived actinomycete of the genus Nocardiopsis.
    Leutou AS; Yang I; Le TC; Hahn D; Lim KM; Nam SJ; Fenical W
    J Antibiot (Tokyo); 2018 Jun; 71(6):609-612. PubMed ID: 29467379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro evaluation of beta-lactamase inhibition by latamoxef and imipenem.
    Sotto A; Brunschwig C; O'Callaghan D; Ramuz M; Jourdan J
    J Antimicrob Chemother; 1996 Apr; 37(4):697-701. PubMed ID: 8722535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New beta-lactam antibiotics, carpetimycins C and D.
    Nakayama M; Kimura S; Mizoguchi T; Tanabe S; Iwasaki A; Murakami A; Okuchi M; Itoh H; Mori T
    J Antibiot (Tokyo); 1983 Aug; 36(8):943-9. PubMed ID: 6630063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial activity and chemical modifications of PS-5 at the C-3 side chain.
    Sakamoto M; Yamamoto K; Isshiki K; Ishikura T; Fukagawa Y; Yoshioka T
    J Antibiot (Tokyo); 1990 Oct; 43(10):1254-70. PubMed ID: 2258325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two novel nucleosidyl-peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS.
    Xie Y; Xu H; Sun C; Yu Y; Chen R
    J Antibiot (Tokyo); 2010 Mar; 63(3):143-6. PubMed ID: 20139866
    [No Abstract]   [Full Text] [Related]  

  • 34. Epocarbazolins A and B, novel 5-lipoxygenase inhibitors. Taxonomy, fermentation, isolation, structures and biological activities.
    Nihei Y; Yamamoto H; Hasegawa M; Hanada M; Fukagawa Y; Oki T
    J Antibiot (Tokyo); 1993 Jan; 46(1):25-33. PubMed ID: 8436556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae.
    Lee YR; Baker NT
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1411-1419. PubMed ID: 29675787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoberninamycin, a new antibiotic produced by Micrococcus luteus.
    Biskupiak JE; Meyers E; Gillum AM; Dean L; Trejo WH; Kirsch DR
    J Antibiot (Tokyo); 1988 May; 41(5):684-7. PubMed ID: 3384754
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: A new antibiotic libramycin A.
    Yahagi T; Sugawara H; Uramoto M; Suzuki S
    J Antibiot (Tokyo); 1974 Feb; 27(2):143-4. PubMed ID: 4826087
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibiotic no. 5879, a new water-soluble antibiotic against gram-negative bacteria.
    Miyamura S; Ogasawara N; Otsuka H; Niwayama S; Tanaka H
    J Antibiot (Tokyo); 1972 Oct; 25(10):610-2. PubMed ID: 4648315
    [No Abstract]   [Full Text] [Related]  

  • 39. A new antibiotic X-5108 OF Streptomyces origin. I. Production, isolation and properties.
    Berger J; Lehr H; Teitel S; Maehr H; Grunberg E
    J Antibiot (Tokyo); 1973 Jan; 26(1):15-22. PubMed ID: 4781274
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro evaluation of metal chelators as potential metallo- β -lactamase inhibitors.
    Azumah R; Dutta J; Somboro AM; Ramtahal M; Chonco L; Parboosing R; Bester LA; Kruger HG; Naicker T; Essack SY; Govender T
    J Appl Microbiol; 2016 Apr; 120(4):860-7. PubMed ID: 26849010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.